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(x :t: SEM; n = 15 experiments). This was signif'¢antly (p < 0.05) different 
from the control value, which averaged 2.8 -I- 0.3 days (n = 15). Additional 
analysis of human atharectomy specimens, from 32 coronary and 32 femoral 
plaques of primary (45) and restenotic (19) origin, showed SMC outgrowth 
in 43/64 cases (67%). Interestingly, previous AI therapy was followed by 
significantly (p < @05) lower sucoess, whereas medfcation wifft ~-bleckers, 
Ca-antagonists, nitrates, asl~n or antilipids had no effect. Complementary 
experiments using isolated h~man and rat SMCs revealed no inhibition for 
benazepdlat (24 h preincub~on) on growth cuwes and chemokinesis of 
these ceils. 
We conclude that long-term ACE inhibition strongly induces apoptesis 
of vascular SMCs which ~nt iy  explains the modified SMC outgrowth 
activity. Our data suggest ACE inhibitors to be atlraCtive candidates for the 
regulation of growth processes v/a apoptosis, though previous clinical trials 
(witho=.~t i etreatmant period) have as yet failed to prevent rostenosis. 
[1043-1001 Ion Channel Modulators Differentially Regulate 
Proliferation and Apoptosis of Human P laque  
Smooth Muscle Calls 
Gerhard Bauriedel, Jorgen Heimed, Petra Heidemann, Svan Schluckabier, 
Uldch Welsch. Dept. Int. Med. I and Inst. Anatomy, Univ. of Munich, FRG 
Proliferation of smooth muscle cells (SMCs) is considered to be a central 
mechanism involved in human artariosctemsis, which is possibly modulated 
by tra,smembrans ~on fluxes. Therefore, using SMCs cultivated from human 
plaque tissue removed by directional atherectomy, we screened different ion 
channel modulators for their ~ential, antagonistic effects on SMC prolifera- 
tion. Growth cop, ms were based upon directly measured cell signals (CASY 
1), to qcantifate population ~ubling rates (PDRs). For the testing of ion 
channel modulators, the PDR~_ of treated SMCs were compared to those of 
control cells (= 100%): 
ion Channel Modulator ~3ent Cone. PDR 
C,a 2+ channel eqonist .~ay K 8644 10 -8 M 174%* 
10 -7 M 205%** 
Ca 2+ channel 8n~gonist nicardipine 10 -3 M 85% ne 
10 -7 M 78%* 
10 -s M 47%** 
K + channel activator nioorandil 10 -8 M 77%* 
10 -7 M 49%*" 
(ns - not s/gniflcant; °p < 0.05; **p < 0.01 ) 
Our oxpe, tmentai data show that, even in low concentrations, these agents 
directly and differentially modulate the replicative capacity of human plaque 
SMCs. Additional transmission electron microscopic analysis revealed exten- 
sive celt shrinkage, membrane blabbing and ton'nation of apoptetic bodies 
in SMCs treated with effective, inhibitory doses of nlcardipina or nicorandil, 
signalling typical features of apoptosis. 
In conclusion, our expodmentai results show the inhibitory effects of ion 
channel modulators on SMC proliferation in vitro to be attributable mainly to 
apoptosis. The described model may be helpful in designing and monitoring 
candidates for local drug delivery, before more complex, animal models am 
used, 
~ Amiodarona Inhibits DNA and Protein Synthesis 
in Human Cardiac Fibroblasts 
Augustine E. Agocha, Mahbeubeh Eghbali-Webb. Yale University School of 
Medicine, New Haven, CT 
Little is known about the effect of Aroiedarone, a class lit anti-arrhythroic 
drug on the extmcellular matrix in the heart. Amlodarone antagonizes thyroid 
hormones in various tissues including the heart, We previously showed that 
the proliferative capacity of cardiac tibroblasts, the matrix-producing ceils 
is regulated by thyroid ho,'mones. In this study we compared the effect of 
Amicdarona with that of thyroid hormones on DNA and protein synthesis in 
human cardiac llbroblasts. Cultured human cardiac tibroblaste ware prepared 
front taft ventriculer tissue of extirpated heart. Cells were treated (24 h) w)th 
Arolodarone (5 p.g/rot), 3,3',5-trlledofhyronlne (1"3) (10 nM) or equivalent 
volume of distilled water (control). The synthesis of DNA and protein was 
determined by measuring the incorporation of 3H-tbyroidine and aH-leucina 
in cardiac f~robiasts, respectively. The results showed a decrease In the 
rate oi DNA (64%, p < 0.05) and protein synthesis (36"/o, p < 0.05) in 
Amlodarona-treated cells. T3-tmatment, however, led to 40% (p < 0.05) 
increase in DNA synthesis and 30=/= (p < 0.05) decrease in protein synthesis. 
Amiodarone-treatment of cells in conjunction with Ts led to a net increase in 
DNA synthesis and net value ot protein synthesis comparable to that in control 
cells. These data indicate that Aroiodaroce is an inhibitor of proliferative 
capacity and metabolic activity of cardiac fibroblastS, thereby a regulator 
of matrix production. They also point to a functional antegonlsm between 
Arolodarone and thyroid hormones. The reversal of amtodarone-induced 
inhibition of DNA synthesis by thyroid hormones may have clinical relevance 
in cardiac patientS with thyroid gland dysfunction. 
Ant ioxidant Dietary Supplementat ion Wilh  
Vitamin E Decreased Atherosclerosis  and 
Cellular Proliferation In Lipid-Fed Rabbits 
Exposed to Passive Smoking 
Bo-qing Zhu, Yi-plng Sun, Richard E. Sievars, Edward P. Norkus, Stonton 
A. Gtantz, Bing-yin Wang, John P. Cooke, William W. Parmley, Prakash 
C. Dasdwania. Universh'y of California, San Francisco; Stanford Univemity, 
CA 
To evaluate the effects of antiox|dants on atherogenasls in a rabbit model 
of hyperchotesteroleroia and passive smoking, 32 New Zealand white male 
rabbits were randomly divided into 4 groups (8 each): Smoke with vitamin E 
(S + E) or without E (S); No-smoke with vit E (C + E) or without E (C). All 
four groups were fed 0.3% chok~terol diet for 13 wks. Two vitan~n groups 
were given dietary vif E 1000 IU and beta-carotene 600 mg/kg chow for 21 
wks (pretreated 8wks before receiving lipid diet). Two groups were exposed 
to passive smoking (4 cigarettes/t5 roin, 6 hours/day) for 10 wks. Alpha- 
Tocopherol concentrations were measured in serum, aorta and omentum. 
Historoorphoroofry and irnmunoh~'tochomistry were performed on segments 
of thoracic aorta using computerized planiroetry and specific antibodies. 
Npha.Tocopheml Aorta Actin 
Group Serum Aorta Omentum Intlrna b'M {g~}# 
(rag/d0" (,g/g)** 0,g/0)" "mine) * (%)" 
S 2.84-0.6 194-2 184-2 u.144.0.05 4.R~1.6 2.54-0.7 
S+E 4.24-1.0 524-9 1084-9  0.044-0.03 1.54-1.3 0.34-0.2 
C 1.44-0.2 104-1 134-3 O.324-0.19 8.94-5.4 t.94-0.7 
G÷E 3.64-0.9 544-13 1214-11 0,034-0.12 1.2:1:0.5 2.14-0.7 
Values are ILion 4. SEM, "p < 0.06, *p < @05, **p < 0.001 for E; Ip = 0.05 for E x S 
(ntera~on) 
Antioxidant dietary supplementation with vitamin E significantly inmeesed 
aipha-tscopherol concentrations in oroenturo, aorta and serum; decreased 
;ntima lesions (fatty streaks), intima/medla (I/M) ratio, and attenuated migra- 
non of smooth muscle cells (alpha-actin) which was enhanced by passive 
smoking. 
Conclusion: Antioxidant dietary supplementation with vitamin E decreases 
atheroeclerosis and cellular proliferation i  the aorta of hypercholastaroleroic 
rabbits exposed to passive smoking. 
I 1043-1031 Effect of  Non-Selective Protein Tyrosine Klnase 
Blocker on Porcine Aortic, Human Arterial, and 
Atheroma-Derived SMC's Prol i feration 
Shmuel Banal, Avlva Schneider, David Gerlz, Gershon Golomb, 
Alexander Levitzki, Yehuda Wolf. Bikur Cholim Hospital, Hada,cc~ah Medical 
Center, The Hebrew Univers#y, Jerusalem, Israel 
Accelerated proliferative response of smooth muscle cells (SMC's) to vessel 
wall injury is the principal cause of premature coronary occlusion in patientS 
undergoing heart ransplantation, coronary artery bypass grafting, and PTCA. 
Pmtsin tyrosine kinases (PTK) activity is involved in multiple steps of signal 
transduction of SMC's growth racism. It is essential for normal call prollfar- 
align, and greatly amplified in proliferative disorders. Blocking the activity of 
tymsine kinases may provide a unique and useful strategy for the treatment 
of syndromes involving acoelerated proliferation of vascular SMC's. We ex- 
aroined the inhibitory effect of AG-17, a potent non-specific PTK blocker, 
on porcine aortic SMC's, human internal roammary artery (IMA) SMC's and 
human SMC's derived from carotid artery atheremas. 1 uM, 10 uM or 100 
uM AG-17 dissolved In 0.1% DMSO was added to the cultures 1, 3 and 5 
days after seeding. On day 7 cultures ware washed and cells ware allowed to 
recover. Control c,JltUraS were treated with 0.1% DMSO. Cells were counted 
on days 7 and 15. The degree of inhibition of SMC's proliferation is shown 
fn the table. As shown, AG-17 is a very effective inhibitor of SMC's growth. 
Porcine SMC's were more sensitive to the inhibitory effect of AG-17. 10 uM 
caused 92°/= inhibition and 100 uM was toxic to the cells. The inhibition of 
porcine SMC's proliferation was not reversible, and the cells did not resumed 
proliferation after day 7. 100 uM AG-17 caused 92% and 70% Inhibition of 
human IMA and human atherema SMO's respectively and had no toxic effect 
on the ceils. This inhibition of human SMC's was reversible. 
% Inhib~lon of SMC's Proliferalfon: 
SMC's 1 .M 10 .M 100 .M 
Pordne 45% 92% 100% 
IMP, 3% 60% 92% 
Atheroma 5% 34% 70% 
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Go~fus/ons: AG-170 a non-sped~ FIX bloder is a potent inhibitor of 
porcine and human SMC's pmf/femtion, in the highe~ doses tested it had 
toxic elfests on porcine SMC's but not on the human cells. 
11043-1041 Felodlplne Attenuates Monocyte-EndotheUal 
Int~vaction and Inhibits Intimal Le~lon 
Formation In the Hylpercholesterolemlc Rabbit 
Bing-yin Wang, Jose' Niebau~, Nan H. Singer, Philip S. Tsao, John 
P. Cooke. Stanford Univem~, S tan~ CA 
~ entry antagonists have boen shown fo inhibit the ~eve~ of 
new lesions in hypercholestemlemic animals and humans. New lesion for- 
marion requires monocyte adhesion to the andothelium. The ixalx)se of this 
study was to dofennine if the cak:ium ant~y antagonist feled'q:~ne inhibited Inti- 
ma] lesion formation by inhibiting monocyte and/or endothelial determinants 
of adhesion. Mele NZW rabldts (n = 28) recebed tha foliowing trealmem 
reglrnsn for I0 weeks: NonnM chow (NP, n = 3); normal dxw~ wlth fekxrq0ine 
infusion (NF, n = 6); 0.5% cholesterol chow (CP, n = 12); or 0.5% cholesterol 
chow ond feind~ne infusion (CF, n = 7). After 10 weeks blood was collected 
for Uochendc~ measurements and mononudear ~1 Uno~ng ~a~m, and 
thoracfo andae were harvested for vescular rean~ studles, monenudear 
cell bino~g assays and hisfomoq0homet~. In the NF animals, felodildne at 
this dose did not significantly elfect blood pressure, serum cholesterol levels, 
binding studies, vascular reactivity, or structure. Plasma cholesterol levels 
were slgniFcanSy elevated in groups receiving the 0.5% cholesterol diet (N, 
29 ~ 3; CP, 1221 ~ 73; and CF, 979 • 108 mg/dl res t ) ,  and the 
adhesiveness of mononudear cells markedly augmented (by 250%). After 
thoracic aortae (from CP, n = 5) were incubated with feloo~ne (10 -7) for 
1 hour, mononuclear cell adhesion was markedly attenuated (74 :l: 9% vs 
100%, p < 0.0~). ImpUted enduthelium-depedent relaxa~ons (to acotyt- 
choline) in the hypemholesterolemio group were restored by felodipine Veat- 
ment (40 -~- 7% vs 58 ~ 4% vs 67 d: 5%; CP vs CF ve NF mspestively). This 
effect was associated with a 2.2-fold reduction in lesion surface area of the 
thoracic aorta (8.2 :E 6.3% vs 18.2 -I- 9.5%; CF vs CP; p = 0.055). Moreover, 
the Intimal-medial r Uo ~ng lesion thickness was substantially mducod 
by fekxl'@ne tmatmant (0.05 ~ 0.02 vs 0.17 ~ 0.06; CF vs CP; p = 0.025). 
In conduslen, low-dose felodipine attanuate~ endothelial determinants of 
adhesion and inhibits the formation of lesions in hypercholnsterolemic ani- 
mals. Feind~ne has direct inhibitory effects upon endothelial adhesiveness; 
in ~n,  it enhances vascular nitric oxide activity which may also reduce 
endothelial adhesiveness. 
[ 1043-105 ] A Synthetic Chlodn DedvaUve, Tin Ethyl 
Etlopurpurin, Inhlblt~ Smooth Muscle Cell 
Proliferation Without Light Activation 
Wigiam D. Coats Jr., Jesse W. Cumer, Hugh L Nal~so 1o David P. Faxon. 
University or Southern California, Los Angeles, CA; 1 PDT, ~ l a r  
Inc., Santa Barbara, CA 
Smooth muscle cell (SMC) proliferation is a major component of restenosis. 
Hematoporphydn derivative and other photosensitive compounds (PC's) in- 
hibit pmllfomtion by caudng cell necrosis upon light activation (photodynamic 
therapy, (PDT)). Some PC's, such as benzoporphyfin derivative (BPD), have 
been suggested to have non-cytotoxic antiproliferative flects without PDT, 
although the results of several different studias utilizing BPD remain con- 
tmvemiaL We investigated the inhlbltoq/effect of a novel photosensitive, 
synthetic hlorin dedvetlve, tin ethyl etiopurl~dn (SnETe), on SMC prolifor- 
ation without PDT in an in vitro model of vascular injury. The lilac arteries of 
New Zealand White rabldis randomized into 4 groups were b~lconsd-injured 
2 hours post intmvanous infusion of placebo (control, (C)) or SnETe (1, 2, 
4 mg/~). The rabbits were injected 46 bouts later with bromodeoxyuddine 
(B~dU, 30 mg~g) end then eu~mnized after 2 hours. SMC prollfem~n was 
assessed by quantitatJon of immunehistochemlcally detected BrdU i ~  
ration in 5 separate lilac sections obtained from the site of injury. Thee 
was a d o s e ~  and significant inhlbitinn of SMC pmlifera~n at ell 
concenlratiorls of SnET2 VelSUS C (p < 0.05). The high dose of SnET2 (4 
mg/kg) inhibited SMC proliferation by >_ 90% of C (p = 0.02). The apparent 
ICso value for half-maximel inhibi,on occurred over a wide range at 1--2 
mglkg SnET2. Light microscopic examination revealed the absence of any 
colluler necrosis or nuclear pyknosls in the C or SnET2 treated groups. These 
results suggest that SnET~ may provide a novel and potent therapy in the 
treatment of mstenosis through inhibition of SMC proliferation w~out PDT 
Or cytotoxicily. 
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• Hypoxla Enhances inf lammatory Regulation of  
E-Selectin Through a cAMP-Dependent Pathway 
Grogor Zund, David R Nelson, Blis J. Neufeld, Andrea L Dzus, 
Joyce Blschotf, John F- Mayer Jr., Sean P. Coigan./~n.ard Med/c# Schoo/, 
Boston, MA 
In many vascular diseases, ~ hypoxia ocours in conjunction with other 
inflammafo~ IXOcoSSeS. Given the invelveme~ of leukocyt~ in tissue dam- 
age during retx~fusion ~ju~/, we I~t~¢F~d mat hypox~ may crdferen~ 
rugulat~ expression of an impertant ~ adhesion molecule, E-selectin 
(ELAM-1). Bovine aodic endothelial monolayem were exposed to hypoxia 
(~ 3 ton') in the pmsenne Or absence of tomor-nectosis factor-e (TNF-a) 
or 6 p o p o ~  (LPS), ~ reguisfon; of E-selectin. Endotheflal cell 
sudaue E-selectin was qum-¢,;t~ed by whole cell ELISA and by immuno- 
preC~n using ~ anti-E-selectin sera. Endothelial mRNA levels 
were ansassed using ~ Ixoteclk)n assays. TNF~ or LPS induced 
a time- and dose-dependant induclion of spedf'¢ E-selectin surface expres- 
sion under normoxic onditions. Hypoxia per se, did not induce endothelial 
E-selectin expression, bowever, the conddnaIMn of TNF-~ or LPS and hy- 
poxia msultod in enhancod induction of eedothelial E-sele~n exl~resston (85 
d: 10 and 108 + 8% ovor LPS aed TNF-a ainne, respectively, both p > 0.001). 
DensitomeW of i r ~  horn hypoxio/LPS mveMeO a 270% 
increase over nomloxia/LPS, mRNA levels of hypoxic endotheEa were in- 
creased 190% over nermoxle ~t  edddion of TNF-=, 10ut were not inereased 
by hypoxia alone. Finally, we and othes have shown an hypoxle-elk~tod 
decrease in endothelial cAMP (>50%). Adddian of fomkolin (cAMP agonist, 
10 pM) and ~xanth ine  ( p h o ~  inhibitor, 5 mM) 
during hypoxia resulted in no~aF~.atJon of cAMP and a loss of enll~,-,,:,~T~ 
E-seinctfon surface expresdon with TNF-e and hypoxia. We conclude that 
hypoxin stress enhances LPSKNF-~ induction of E-selectin and is, at least 
th pint, cAMP-de~ From such data, we speculate that hypoxic slms~ 
may represent a pathophysiologicany-relevent stimuli during conditions of 
inflammation. 
11044'1071 Selective Activation of  Endothelin Receptor 
(ERR) Promoters Outing Differentiation: 
Analysis o f  Cis-Actlng Elements 
Juen C. Monge, Mitchefl Schipper, Chados Constsntine, David Kryl, 
Peter ~ Ouncan J. Stewart. McGin Un/.exs/ty, Mormea/, Quebe~ 
~ "  Univemi~ of Tomtrto, Toronto, Onta#o, Canada 
The interaction of ETs with their receptors plays a critical role in the de- 
vefopmant of cardiac and vagal hemal Orest-dedved smctums including 
the intewantdoular septun~ outflow tract and great vessels (ETol/ETA), and 
ganglionic neurons (ET-3/ETs). We have Shown the selective induction of 
ETA or ETa during ddferentia~n of the pludpotential embryonal cell line 
P19 to a camlomyocy~ Or a neural I~neage, ~ .  in order to de- 
fine tissue-specific e~anants, P19 cells were lmnsfected with ET^ or ETa 
pmmofor-ludferase conslncts. The region -848 to +92 of ETA induced lu- 
ciferase expresslen in the cells d i f f~  to a myocyte linoage but not in 
the undilferantia~d cells. Oeletion analysis identified two slmng positive reg- 
ulatmy elements ( -  116 to -38 and +90 to +200), both of which were ~ to 
markedly enhance the ac~ of a heterologous promoter in cells expmss~g 
ETA. Selective induction of the ETB-Iuciferase constnct with dflfemntJa~on 
to a neural lineage was snen with the fragment -1108 to +250 of the ETs 
gem), and deletion ot patant ne~ tugt~ e leT~ (--1100 to --200) 
ptoducod a 23-fold increase In promoter activity. Conclusions: 1) ~ is se- 
lec~ve d ~ ~  acthrabon of cis-ac~ng elemonts in the ETR 
promoters in a model system resembling ~ and biochemically 
key events of early e n d ;  2) Posi6ve diff emn'datlen-spec~¢ as well 
as negative rugulatoly elements are involved. 
,I 1044-108]  Cell-Specific In t~ct ion  of  Nuclenr Factors With 
a Cis-aeting Negative Regulatory Element in the 
Rat Cardiac Alpha Myosin Heavy Chain Gene 
Medhu Gupta~, Mabosh P. Gupla. Dept. of Med/c/ne, The Un/vePa~ of 
Chicago, Chicago, Ilrnlois: 1 The Heart Institute for Children, Christ Hospital 
Medical Cenfo~, Oak Lawn, IITmois 
The alpha myosin heavy chain (wMHC) gane encodes an isofon~ of a major 
contra~le protein of the heart, the myosin heavy chain. Expression of =-MHC 
